Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera vs Darbepoetin Alfa for Renal Anemia in CKD Not on Dialysis
NCT00559273Phase 3Completed
- Sponsor
- Roche
- Start
- Dec 2007
- Primary completion
- Oct 2009
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 16
01
Overview
A Phase 3 trial of methoxy polyethylene glycol-epoetin beta in anemia of chronic kidney disease, sponsored by Roche. Started Dec 2007; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT00559273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00559273.